Appropriate diagnosis and treatment can reduce the frequency of seizure episodes, prevent complications and reduce the risk of sudden unexplained deaths in patients with epilepsy. Over the last few decades, the management of epilepsy has made tremendous progress in terms of both medical and surgical m...
Infrequent/Mild Medical/Treatment Information This version adds some general performance improvements and bug fixes. We are so very grateful for all your love for Epsy! If you like the Epsy app, please take a moment to write a review. Rating and reviews help us help more people, plus we ...
Progress in Epilepsy Latest Waves of DiscoveryThis Viewpoint discusses recent advances in the understanding of seizure disorders and future pathways of discovery for the treatment of epilepsy.Kleen, Jonathan K.Lowenstein, Daniel H.JAMA neurology
Today on Medscape : Get the latest medical news, clinical trial coverage, drug updates, journal articles, CME activities & more on Medscape. A free resource for physicians.
ARBs Cut Epilepsy Risk in Patients with Hypertension Medscape Medical News20 minutes ago Orthostatic Rises in SBP Not Tied to Increased CVD Risk Medscape Medical News1 hour ago General Anesthesia for C-Sections: A Mental Health Risk? Medscape Medical News2 hours ago ...
Find all the latest on treatment option at Medical Xpress. Your go-to source for news, research, and medical breakthroughs.
New treatment helps bring movement back to people who've suffered a stroke The treatment is also used to treat depression and epilepsy, Jan 24 Wegovy weight loss drug has heart benefits, study found A clinical trial found Wegovy reduced the risk of heart attack, stroke, and heart-relate...
DRUG DELIVERY - Advancements in Transdermal Delivery Systems: A Focus on Invisicare® Technology for Obesity Treatment James A. Roszell, PhD, and Doreen McMorran demonstrate how this technology has demonstrated potential in the transdermal administration of glucagon-like peptide-1 (GLP-1) agonists ...
DRUG DELIVERY - Advancements in Transdermal Delivery Systems: A Focus on Invisicare® Technology for Obesity Treatment James A. Roszell, PhD, and Doreen McMorran demonstrate how this technology has demonstrated potential in the transdermal administration of glucagon-like peptide-1 (GLP-1) agonists ...
Epilepsy is a common and debilitating brain disorder for which current antiseizure medications (ASMs) provide inadequate efficacy in around 30% of patients. In their Review, Pavel Klein and colleagues survey the diverse ASM pipeline, including new approaches to target specific epilepsy syndromes, and...